:quality(80):format(png)/default_images/avatar_default.png){kind=avatar}
:quality(80):format(jpeg)/posts/2021-10/13/featured-6e140ec3a34449454639580e444db92d_1634109792-b.jpg)
Vaksin Zifivax adalah vaksin Covid-19 terbaru yang mendapat izin penggunaan darurat atau emergency use authorization (EUA) dari Badan Pengawasan Obat dan Makanan (BPOM) Indonesia. BPOM merilis izin penggunaan darurat atau EUA untuk vaksin Covid-19 Zifivax pada 7 Oktober 2021.
Berdasarkan keterangan resmi di situs Badan POM, Zifivax adalah vaksin Covid-19 yang berasal dari perusahaan di di China. Di Indonesia, hak izin penggunaan darurat vaksin Covid-19 Zifivax diberikan kepada PT Jakarta Biopharmaceutical Industry (JBio).
Berikut fakta tentang Vaksin Zifivax yang telah dirangkum agar kamu lebih kenal dengan vaksin ini.
1. Dosis yang Diberikan Sebanyak 3 Kali
:quality(80):format(jpeg)/entries/2021-10/13/28882-1-6800154f20d42cb023ad9170287a5847.jpg)
https://news.cgtn.com/
Vaksin Covid-19 Zifivax akan diberikan tiga dosis dalam rentang tiap satu bulan dari dosis pertama ke dosis berikutnya. Pemberian tiga dosis vaksin ini ditujukan untuk memberikan perlindungan yang lebih aman.
2. Efikasi Sebesar 81%
:quality(80):format(jpeg)/posts/2024-04/18/featured-60232cb8b304ab3f55577f4466cfb10e_1713454061-b.jpg)
:quality(80):format(jpeg)/members/avatar/anggun-septia-064cbf099420f5a54716c948c01be55d-s.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-aa85e8d20440f52b8244f6a28b6fcf6b_1713453744-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-0bd8fe5ab8926987b0e8ea8ea5fa25de_1713453260-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/17/featured-9b43b76bf522006525406b49b61c5d28_1713362018-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/16/featured-6d221b9b6516c834970f175424f9df9e_1713282903-b.jpg)
:quality(80):format(jpeg)/members/avatar/riswinanti-permatasari-dc742d658ef092d6a4a6899e5601ace0-s.jpg)
:quality(80):format(jpeg)/posts/2024-04/16/featured-0aeefb73ec8c73e95a706b2f07a2378d_1713282344-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/16/featured-77a750b8aec51e579c9425544811fe77_1713270657-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/16/featured-5ec80ad99829c0c71c258b45ef73dfae_1713267731-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/16/featured-286d705c1dd66569610ccfac4448f60c_1713204481-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/15/featured-257aa07603c147daeb77fc6b5dae2f78_1713145184-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/15/featured-713c5a4277109c6b1794b6bee936ffa8_1713143565-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/15/featured-3372a6696ef39442a2831035ecbb2704_1713142987-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-a7342e12cdb6c92460e223cbd233aef8_1713420252-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/17/featured-816b5868fa0d97fb50f7183a92035b2d_1713365942-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/17/featured-bc611447cfe58fd0b92dae188cf4661b_1713365650-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/17/featured-6c785dfb07e1ee06c6977980a3cf5883_1713317218-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-54bbb10c095c60c5444326611f2ec9f7_1713410883-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/14/featured-f98f581f497b34f339387030cd9df956_1713106520-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/12/featured-f73711e81e371f89cb35f4b0f7e25579_1712888981-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/10/featured-e2412933fc0c1938eaa57a16ad3d0f47_1712725639-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-60232cb8b304ab3f55577f4466cfb10e_1713454061-b.jpg)
:quality(80):format(jpeg)/posts/2024-04/18/featured-aa85e8d20440f52b8244f6a28b6fcf6b_1713453744-b.jpg)